Announced
Completed
Financials
Tags
Germany
Completed
Majority
Cross Border
Single Bidder
Friendly
Acquisition
research company
Test Inspection and Certification (TIC)
Private
Synopsis
Huma Therapeutics, a digital health company, completed the acquisition of Alcedis, a clinical research and technology. Financial terms were not disclosed. "We are excited to be joining the Huma family, bringing our clinical trials expertise and capabilities to combine with those of Huma's award-winning technology-platform. Together, we will offer substantially greater benefit to pharmaceutical, medtech, clinical research organisation, and academic partners for their research projects," Hanno Härtlein, Alcedis Managing Director.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.